尽管新型抗菌素的使用使许多感染性疾病得以控制,但是临床上单用抗菌素治疗某些耐药菌株、特别是革兰氏阴性菌弱毒株所致感染,效果往往不理想。这些感染常发生于先天性或继发性免疫功能不全的病人。近年,日本以静脉注射免疫球蛋白(以下简称:静注免疫球蛋白)与抗菌素合 Although the use of new antibiotics has led to the control of many infectious diseases, the clinical use of antibiotics alone to treat certain resistant strains, especially those caused by attenuated strains of Gram-negative bacteria, is often not effective. These infections often occur in patients with congenital or secondary immune insufficiency. In recent years, Japan intravenous immunoglobulin (hereinafter referred to as: intravenous immunoglobulin) and antibiotics